Stephanie Cincotta Valcourt, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychomotor Agitation | 3 | 2016 | 279 | 0.420 |
Why?
|
| Antipsychotic Agents | 6 | 2019 | 3015 | 0.390 |
Why?
|
| Patient Simulation | 2 | 2016 | 317 | 0.260 |
Why?
|
| Psychotic Disorders | 3 | 2006 | 2669 | 0.170 |
Why?
|
| Clozapine | 1 | 2019 | 477 | 0.160 |
Why?
|
| Schizophrenia | 4 | 2019 | 6549 | 0.150 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2005 | 477 | 0.120 |
Why?
|
| Benzodiazepines | 1 | 2007 | 1040 | 0.110 |
Why?
|
| Quinolones | 1 | 2005 | 448 | 0.110 |
Why?
|
| Drug Utilization | 1 | 2007 | 1248 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2016 | 4632 | 0.100 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1683 | 0.100 |
Why?
|
| Bipolar Disorder | 2 | 2007 | 4998 | 0.090 |
Why?
|
| Whole-Body Irradiation | 1 | 1989 | 464 | 0.090 |
Why?
|
| Psychiatry | 2 | 2016 | 1502 | 0.090 |
Why?
|
| Hospitalization | 2 | 2007 | 9304 | 0.080 |
Why?
|
| Internship and Residency | 2 | 2016 | 5322 | 0.080 |
Why?
|
| Radiation Protection | 1 | 1989 | 482 | 0.070 |
Why?
|
| Overweight | 1 | 2006 | 2139 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3875 | 0.070 |
Why?
|
| Weight Loss | 1 | 2006 | 2396 | 0.070 |
Why?
|
| Piperazines | 1 | 2005 | 2576 | 0.070 |
Why?
|
| Depressive Disorder, Major | 1 | 2005 | 4299 | 0.040 |
Why?
|
| Obesity | 2 | 2006 | 11700 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2007 | 561 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2007 | 6632 | 0.040 |
Why?
|
| Mathematical Computing | 1 | 2005 | 149 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2007 | 6389 | 0.040 |
Why?
|
| Body Weight | 2 | 2007 | 4804 | 0.040 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2005 | 128 | 0.040 |
Why?
|
| Hospitals, Psychiatric | 1 | 2005 | 339 | 0.030 |
Why?
|
| Self-Assessment | 1 | 2016 | 392 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 11616 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2006 | 461 | 0.030 |
Why?
|
| Lung | 1 | 1989 | 9182 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2005 | 472 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2005 | 1899 | 0.030 |
Why?
|
| Models, Structural | 1 | 1989 | 378 | 0.020 |
Why?
|
| Schizophrenic Psychology | 1 | 2007 | 1681 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 1095 | 0.020 |
Why?
|
| Counseling | 1 | 2006 | 1447 | 0.020 |
Why?
|
| Adult | 6 | 2016 | 211400 | 0.020 |
Why?
|
| Teaching | 1 | 2016 | 1213 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2006 | 2560 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 5182 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 6970 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2007 | 2764 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 2760 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2006 | 60991 | 0.020 |
Why?
|
| Inpatients | 1 | 2005 | 2050 | 0.020 |
Why?
|
| Humans | 9 | 2019 | 686663 | 0.020 |
Why?
|
| Male | 6 | 2016 | 352465 | 0.020 |
Why?
|
| Curriculum | 1 | 2016 | 3114 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 9114 | 0.020 |
Why?
|
| Female | 6 | 2016 | 375459 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2005 | 2754 | 0.020 |
Why?
|
| Length of Stay | 1 | 2005 | 6241 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2006 | 8882 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2006 | 8529 | 0.010 |
Why?
|
| Exercise | 1 | 2006 | 5078 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2005 | 7865 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 12323 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2007 | 6378 | 0.010 |
Why?
|
| Middle Aged | 3 | 2007 | 216468 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 84957 | 0.010 |
Why?
|
| Aged | 1 | 2005 | 162271 | 0.000 |
Why?
|